Table of Contents

company-logo

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ImmuCell Dividend Announcement

• ImmuCell does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ImmuCell dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ImmuCell Dividend History

ImmuCell Dividend Yield

ImmuCell current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ImmuCell stock? Use our calculator to estimate your expected dividend yield:

ImmuCell Financial Ratios

P/E ratio-0.06
PEG ratio-0.00
P/B ratio1.54
ROE-2833.46%
Payout ratio0.00%
Current ratio3.11
Quick ratio1.44
Cash Ratio0.85

ImmuCell Dividend FAQ

Does ImmuCell stock pay dividends?
ImmuCell does not currently pay dividends to its shareholders.
Has ImmuCell ever paid a dividend?
No, ImmuCell has no a history of paying dividends to its shareholders. ImmuCell is not known for its dividend payments.
Why doesn't ImmuCell pay dividends?
There are several potential reasons why ImmuCell would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ImmuCell ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ImmuCell has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ImmuCell a dividend aristocrat?
ImmuCell is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ImmuCell a dividend king?
ImmuCell is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ImmuCell a dividend stock?
No, ImmuCell is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ImmuCell stocks?
To buy ImmuCell you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ImmuCell stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.